Price $72.05 |
Market Cap
913.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
50.4
|
P/B
3.16
|
P/S
1.62
|
Dividend %
-
|
|
P/CF
103.9
|
P/FCF
86.7
|
Op. Cash Flow
15.7K
|
FCF
0.7
|
|
Op. Margin
4.70%
|
Net Margin
3.20%
|
ROE
6.90%
|
ROI
6.80%
|
|
ROA
4.60%
|
EPS Growth
13.00%
|
Current Ratio
3.0
|
Debt/Equity
6.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Dyadic International, Inc. (DYAI) | $5.83 | - | - | 120.1M | Strong Buy |
| Milestone Scientific Inc. (MLSS) | $0.33 | - | - | 13.3M | Strong Buy |
| CYANOTECH CORP (CYAN) | $3.03 | - | - | 18.3M | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLN) | $0.87 | - | - | 16M | Strong Buy |
| Hologic, Inc. (HOLX) | $47.84 | - | - | 11.78B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
